Walking Football as a Supportive Medicine for Patients With Prostate Cancer
Is the Walking Football a Feasible Approach to Improve Health-related Quality of Life in Men With Prostate Cancer Receiving Androgen Deprivation Therapy? the PROSTATA_MOVE Randomized Controlled Trial.
1 other identifier
interventional
50
1 country
1
Brief Summary
Androgen deprivation therapy (ADT) is widely used in men with prostate cancer (PCa) to delay disease progression and enhance survival. The use of ADT is often associated with a vast spectrum of side effects that considerably reduce quality of life. Exercise has been proposed as a non-pharmacological strategy to counter some adverse effects of ADT among patients with PCa. Particularly, recreational football-based interventions have been suggested as an enjoyment approach to involve patients with PCa in regular exercise practice. Given its intermittent nature and vigorous efforts, adverse events associated with recreational football practice have been reported. To handle this issue and to involve patients with PCa in recreational football practice, walking football has emerged as a more suitable exercise modality
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable prostate-cancer
Started Jul 2019
Shorter than P25 for not_applicable prostate-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 11, 2019
CompletedFirst Submitted
Initial submission to the registry
August 8, 2019
CompletedFirst Posted
Study publicly available on registry
August 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedJanuary 13, 2020
January 1, 2020
11 months
August 8, 2019
January 9, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Recruitment rate.
Assessed by the number of enrolled patients divided by the number of invited patients.
Baseline
Withdrawal rate
Assessed by the number of withdrawal patients
Change from baseline to 32 weeks
Appropriateness of outcomes assessments.
Assessed by the percentage of completed data.
Change from baseline to 32 weeks
Adherence to intervention.
Assessed by the number of completed sessions and the number of missed sessions.
Change from baseline to 32 weeks
Rate of Enjoyment
Assessed by the self-reported exercise sessions' enjoyment using a likert scale (1 \[lowest\] to 5 \[highest\] points).
Change from baseline to 32 weeks
Health-related quality of life
Using EORTC PR25, EQ-5D-5L and SF-6D questionnaire.
Change from baseline to 32 weeks
Secondary Outcomes (29)
Bone Mineral Density
Change from baseline to 32 weeks
Body composition
Change from baseline to 32 weeks
Aerobic capacity
Change from baseline to 32 weeks
Maximal isometric handgrip strength
Change from baseline to 32 weeks
Maximal isometric lower limb strength
Change from baseline to 32 weeks
- +24 more secondary outcomes
Study Arms (2)
Interventional group
ACTIVE COMPARATORWalking football training
Control group
NO INTERVENTIONUsual care
Interventions
Intervention will involve 3 sessions per week of a structured and supervised walking football program over 16 weeks. Each session will include a warm-up, followed by the practice of specific exercises where specific technical skills (pass, dribble, shot), motor skills (agility, coordination, balance) and physical fitness (cardiorespiratory and musculoskeletal capacity) will be enhanced, ending with a structured game (7x7) of walking football and a cooldown.
Eligibility Criteria
You may qualify if:
- Patients diagnosed with PCa
- Under castration therapy for more than 3 months
- Planned to be under castration for more than 6 months
- Follow-up at the Medical Oncology department and/or Urology department of the Hospital Center Vila Nova de Gaia/Espinho.
You may not qualify if:
- Medical or surgical contraindications for exercise.
- T-score \< -2.5
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Associacao de Investigacao de Cuidados de Suporte em Oncologialead
- Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.collaborator
- University of Beira Interiorcollaborator
- Federação Portuguesa de Futebolcollaborator
- University Institute of Maiacollaborator
- Câmara Municipal de Gaiacollaborator
Study Sites (1)
Centro Hospitalar Vila Nova de Gaia / Espinho
Vila Nova de Gaia, Portugal
Related Publications (1)
Capela A, Antunes P, Coelho CA, Garcia CL, Custodio S, Amorim R, Costa T, Vilela E, Teixeira M, Amarelo A, Silva J, Joaquim A, Viamonte S, Brito J, Alves AJ. Effects of walking football on adherence, safety, quality of life and physical fitness in patients with prostate cancer: Findings from the PROSTATA_MOVE randomized controlled trial. Front Oncol. 2023 Mar 21;13:1129028. doi: 10.3389/fonc.2023.1129028. eCollection 2023.
PMID: 37025594DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andreia Capela, MD
Centro Hospitalar Vila Nova de Gaia / Espinho, EPE
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical oncologist at Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.
Study Record Dates
First Submitted
August 8, 2019
First Posted
August 20, 2019
Study Start
July 11, 2019
Primary Completion
May 31, 2020
Study Completion
June 30, 2020
Last Updated
January 13, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share